Marqués, M.; Sorolla, M.A.; Urdanibia, I.; Parisi, E.; Hidalgo, I.; Morales, S.; Salud, A.; Sorolla, A.
Are Transcription Factors Plausible Oncotargets for Triple Negative Breast Cancers? Cancers 2022, 14, 1101.
https://doi.org/10.3390/cancers14051101
AMA Style
Marqués M, Sorolla MA, Urdanibia I, Parisi E, Hidalgo I, Morales S, Salud A, Sorolla A.
Are Transcription Factors Plausible Oncotargets for Triple Negative Breast Cancers? Cancers. 2022; 14(5):1101.
https://doi.org/10.3390/cancers14051101
Chicago/Turabian Style
Marqués, Marta, Maria Alba Sorolla, Izaskun Urdanibia, Eva Parisi, Iván Hidalgo, SerafÃn Morales, Antonieta Salud, and Anabel Sorolla.
2022. "Are Transcription Factors Plausible Oncotargets for Triple Negative Breast Cancers?" Cancers 14, no. 5: 1101.
https://doi.org/10.3390/cancers14051101
APA Style
Marqués, M., Sorolla, M. A., Urdanibia, I., Parisi, E., Hidalgo, I., Morales, S., Salud, A., & Sorolla, A.
(2022). Are Transcription Factors Plausible Oncotargets for Triple Negative Breast Cancers? Cancers, 14(5), 1101.
https://doi.org/10.3390/cancers14051101